Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Marjoram extract is a botanical extract derived from the leaves of *Origanum majorana* (sweet marjoram). It has been traditionally used in Middle Eastern folk medicine and is investigated for its potential anti-inflammatory, antioxidant, immunomodulatory, and anticancer properties. In vitro and in vivo studies suggest that marjoram extract can induce apoptosis in various cancer cell lines, including breast cancer (MCF-7), by modulating apoptotic markers such as p53, Bax, and Bcl-2. Additionally, clinical and preclinical studies have explored its therapeutic potential in managing hormonal and metabolic parameters in polycystic ovary syndrome (PCOS), where it has been shown to improve insulin sensitivity and reduce dehydroepiandrosterone sulfate (DHEA-S) levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on marjoram extract.